Systemic treatment of colorectal cancer
- 31 December 1994
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (3), 404-409
- https://doi.org/10.1016/0959-8049(94)90266-6
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, andmdr gene expression in colorectal cancerCancer, 1993
- Systemic Infusion Versus Bolus Chemotherapy with 5-Fluorouracil in Measurable Metastatic Colorectal CancerAmerican Journal of Clinical Oncology, 1992
- Sequential methotrexate and 5-fluorouracil (FU) vs. FU alone in metastatic colorectal cancerAnnals of Oncology, 1992
- Biochemical modulation of 5-fluorouracilCancer Treatment Reviews, 1990
- Superiority of sequential methotrexate, fluorouracil, and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: a randomized trial.Journal of Clinical Oncology, 1989
- Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.Journal of Clinical Oncology, 1989
- A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.Journal of Clinical Oncology, 1989
- Prognostic factors in advanced colorectal carcinomaThe American Journal of Medicine, 1983
- Phase I study of protracted venous infusion of 5-fluorouracilCancer, 1981
- A phase III study comparing the clinical utility of four regimens of 5-Fluorouracil.A preliminary reportCancer, 1977